Pendox Instruments Ltd. is a pioneering medical technology company dedicated to advancing reproductive medicine through innovation. We specialize in the integration of microfluidic technology, point-of-care testing (POCT), and AI-driven morphological analysis to deliver smart, efficient, and accessible fertility diagnostic solutions.
Our R&D team developed China's first home-use CASA system in 2017, and the first fully automated CASA system in 2018—marking significant milestones in the evolution of reproductive diagnostics.
At Pendox, our mission is to reshape the future of fertility diagnostics with intelligent, user-centric technologies—empowering better health outcomes, supporting reproductive journeys, and contributing to the future of life itself.
Pendox's AI-driven compact fully automated CASA system for human fertility is coming soon in late 2025.